上海儒百生物(Schbio Biotech)
专业血液免疫学产品生产商

Product Description
Human B7-2 / CD86 Protein, Human Fc tag
在线客服
Brand : RecProtein®
Synonym : CD86,B7-2,B70,CD28LG2,LAB72,MGC34413
Molecule : B7-2
Catalog : B1396
Qty : 1mg, 5mg
18521561575  需求咨询
Datasheet

Source

Human B7-2, Fc Tag   (H-B7-2-2)   is expressed from human 293 cells (HEK293). It contains AA Leu 26 - Pro 247 (Accession # AAH40261).

Predicted N-terminus: Leu 26


Molecular Characterization

This protein carries a human IgG1 Fc tag at the C-terminus.


Endotoxin

Less than 0.01 EU/mg by the LAL method.


Purity

>95% as determined by SDS-PAGE.


Bioactivity

ELISA

BIACORE (With our Research Grade Biosimilar Antibody products);


Formulation

Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, pH7.5. Normally trehalose is added as protectant before lyophilization.


Reconstitution

Please see Certificate of Analysis for specific instructions.

For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.


Storage

For long term storage, the product should be stored at lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

No activity loss was observed after storage at:

4-8°C for 12 months in lyophilized state;

-70°C for 3 months under sterile conditions after reconstitution.


Background

Cluster of Differentiation 86 (CD86) is also known as B-lymphocyte activation antigen B7-2, is a type I membrane protein that is a member of the immunoglobulin superfamily, and is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells. Additionally, B72 is expressed at low levels on monocytes and can be upregulated through interferon γ. CD86 is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD86 works in tandem with CD80 to prime T cells. Recent study has revealed that B7-2 promotes the generation of a mature APC repertoire and promotes APC function and survival. Furthermore, the B7 proteins are also involved in innate immune responses by activating NF-κB-signaling pathway in macrophages. CD86 thus is regarded as a promising candidate for immune therapy. CD86+ macrophages in Hodgkin lymphoma patients are an independent marker for potential nonresponse to firstline-therapy.


Reference

(1) Chen C, et al., 1994, J. Immunol. 152 (10): 4929–36.

(2) Yadav, D. et al., 2007, J. Immunol. 178: 6236-6241.

(3) Steidl C, et al., 2010, N. Engl. J. Med. 362 (10): 875–85.



会员登录
登录
其他帐号登录:
留言
回到顶部